We know that the prices for pharmaceuticals are higher in the U.S., but why? 

The U.S. is the world’s largest market for pharmaceuticals, medical devices, and in-vitro diagnostics. Understanding the dynamics can be key to anticipating changes and developing a sustainable strategy. Regardless of your physical location, you should be up-to-date on the current pressures affecting the largest single source of financing and profits amongst these high tech industries.

• What is the organization and trends of drug pricing in the U.S.?
• Who are the principal actors involved in setting drug prices?
• What are the threats for the big pharmaceutical and smaller biotech companies?
• How will these threats shape the impact for innovative therapies?

This conference will be lead by Mark Chanel, Program Director for the Advanced Master in Biotechnology and Pharmaceutical Management at Grenoble Ecole de Management.